加味小青龙汤联合孟鲁司特钠治疗儿童咳嗽变异性哮喘临床观察

Clinical observation of modified Xiaoqinglong decoction and montelukast on cough variant asthma

目的:观察加味小青龙汤联合孟鲁司特钠对儿童咳嗽变异性哮喘的疗效。方法:将134例门诊咳嗽变异性哮喘患儿随机分为治疗组与对照组各67例,对照组给予孟鲁司特钠咀嚼片4 mg,睡前服用;治疗组在孟鲁司特钠咀嚼片基础上加用加味小青龙汤口服,疗程为2周。结果:治疗组总有效率91.04%,明显高于对照组的77.61%,两组比较,具有统计学意义(P﹤0.05)。结论:加味小青龙汤联合孟鲁司特钠治疗儿童咳嗽变异性哮喘临床疗效优于孟鲁司特钠治疗。

Objective:To observe the clinical effect of modified Xiaoqinglong decoction and montelukast on cough variant asthma(CVA)of children.Methods:134 cases of children patients with cough variant asthma were randomly divided into treatment group and control group.67 cases of control group took 4mg montelukast sodium chewable tablets before sleep,while 67 cases of treatment group were treated plus with oral modified Xiaoqinglong decoction on the basis of montelukast sodium chewable tablets.The course of treatment was 2 weeks.Results:The total effective rate of treatment group was 91.04%,which was significantly higher than 77.61%of control group with statistical significance(P﹤0.05).Conclusion:The clinical effect of modified Xiaoqinglong decoction and montelukast on cough variant asthma of children is significant.